Suchen Sie nach Informationen zu Hauptsitz Von Onyx Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://en.wikipedia.org/wiki/Onyx_Pharmaceuticals#:~:text=Onyx%20Pharmaceuticals%20Inc.%20has%20been%20a%20biopharmaceutical%20company,Kevin%20J.%20Kinsella%20and%20Frank%20McCormick%20Ph.D.%2C%20FRS.
https://en.wikipedia.org/wiki/Onyx_Pharmaceuticals
https://www.dnb.com/business-directory/company-profiles.onyx_pharmaceuticals_inc.adea3c9e27d193a053791b390376ddcf.html
Company Description: Onyx Pharmaceuticals' cancer drug is a real gem. Working with health care behemoth Bayer HealtCare Pharmaceuticals, Inc. (Bayer), the California-based biopharmaceutical company developed Nexavar (sorafenib), a small molecule drug that is currently approved for the treatment of advanced kidney cancer and liver cancer.
https://www.crunchbase.com/organization/onyx-pharmaceuticals
Founded Date 1992. Founders Larry Bock. Operating Status Closed. Last Funding Type Venture - Series Unknown. Company Type For Profit. Phone Number (650) 266-0000. Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase ...
http://www.onyx-pharm.com/about-us/
Onyx Pharmaceuticals Reports Second Quarter 2009 Financial Results; Nexavar Global Net Sales Reach $201 Million, 19% Increase Over Second Quarter 2008. 07/29/2009. Onyx Pharmaceuticals Announces Second Quarter 2009 Financial Results Teleconference And Webcast. 07/22/2009.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Onyx Pharmaceuticals gefunden haben.
